Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06959316 · ClinicalTrials.gov registry record

T1D Pregnancy & Me

A clinical trial of Diabetes Mellitus, Type 1 and Pregnancy, High Risk, sponsored by Jaeb Center for Health Research.

Recruiting
Registry status
500
Enrollment target
10
Study locations

NCT06959316 is a study of Diabetes Mellitus, Type 1 and Pregnancy, High Risk that is actively recruiting participants, run by Jaeb Center for Health Research. The registered enrollment target is 500 participants, below the 1,262-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (60% lower). The trial reports 10 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06959316, a study of Diabetes Mellitus, Type 1 and Pregnancy, High Risk, is actively recruiting participants, sponsored by Jaeb Center for Health Research.

RECRUITING
Registry status
500 participants
Enrollment target
10
Study locations

Study Summary

T1D Pregnancy \& Me will partner with pregnant participants living with type 1 diabetes (T1D) in the United States to collect real-world data on management of T1D in pregnancy. This is a remote study where participants can complete online surveys and share device data (continuous glucose monitor (CGM) data and insulin data). Through the collection of CGM, insulin, and pregnancy outcome data, the study will provide important information to understand how diabetes is being managed during pregnancy. These data will provide much needed evidence to guide modern management of diabetes during pregnancy with a goal of improving care and outcomes.

Conditions Studied

Diabetes Mellitus, Type 1 Pregnancy, High Risk Insulin Dependent Diabetes Pregnancy in Diabetics

Interventions

  • DEVICE Hybrid closed loop insulin delivery system

Study Locations (10)

Massachusetts

  • Mass General Brigham - Boston
  • Joslin Diabetes Center - Boston

Alabama

  • University of Alabama at Birmingham - Birmingham

Colorado

  • Barbara Davis Center for Diabetes & University of Colorado Health - Aurora

Florida

  • Jaeb Center for Health Research - Tampa

Indiana

  • Indiana University - Indianapolis

New York

  • Icahn School of Medicine at Mount Sinai - New York

Ohio

  • The Ohio State University - Columbus

Oregon

  • Oregon Health and Science University - Portland

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2025-04-25
Est. Completion 2027-04

Sponsor

Jaeb Center for Health Research

119 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06959316

The ClinicalTrials.gov registry entry for NCT06959316 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,262-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (60% lower). The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 1 intervention - of which Hybrid closed loop insulin delivery system is the first listed.

NCT06959316 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Massachusetts, Alabama, Colorado.

Frequently Asked Questions

What is clinical trial NCT06959316 about?

NCT06959316 is a clinical study titled "T1D Pregnancy & Me". T1D Pregnancy \& Me will partner with pregnant participants living with type 1 diabetes (T1D) in the United States to collect real-world data on management of T1D in pregnancy. This is a remote study where participants can complete online surveys and share device data (continuous glucose monitor (CG...

What is the current status of trial NCT06959316?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2025-04-25. Estimated completion is 2027-04.

What conditions does trial NCT06959316 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 1, Pregnancy, High Risk, Insulin Dependent Diabetes, Pregnancy in Diabetics.

What interventions are being tested in trial NCT06959316?

The interventions under investigation include: Hybrid closed loop insulin delivery system (DEVICE).

Who is sponsoring clinical trial NCT06959316?

This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06959316 being conducted?

This trial has 10 study locations across Alabama, Colorado, Florida, Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus, Type 1

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus, Type 1

All registered trials for this condition

Pregnancy, High Risk

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.